|
US5876727A
(en)
*
|
1995-03-31 |
1999-03-02 |
Immulogic Pharmaceutical Corporation |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
US20020032316A1
(en)
*
|
1995-03-31 |
2002-03-14 |
Cantab Pharmaceuticals Research Limited |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
|
|
US5840307A
(en)
|
1995-03-31 |
1998-11-24 |
Immulogic Pharmacuetical Corp. |
Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
|
|
CA2239058A1
(en)
|
1995-12-14 |
1997-06-19 |
Peter Wirsching |
Anti-cocaine vaccine
|
|
US5817770A
(en)
|
1997-03-21 |
1998-10-06 |
Drug Abuse Sciences, Inc. |
Cocaethylene immunogens and antibodies
|
|
WO1999013907A2
(en)
*
|
1997-09-19 |
1999-03-25 |
Serex, Inc. |
Methods to improve immunogenicity of antigens and specificity of antibodies
|
|
SE9801923D0
(sv)
*
|
1998-05-29 |
1998-05-29 |
Independent Pharmaceutical Ab |
Nicotine vaccine
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US6858211B1
(en)
*
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
US6232082B1
(en)
*
|
1998-12-01 |
2001-05-15 |
Nabi |
Hapten-carrier conjugates for treating and preventing nicotine addiction
|
|
GB2361473C
(en)
*
|
2000-03-08 |
2005-06-28 |
Microgenics Corp |
Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
|
|
GB0031079D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Smithkline Beecham Plc |
Vaccine
|
|
WO2002058635A2
(en)
*
|
2001-01-26 |
2002-08-01 |
The Scripps Research Institute |
Nicotine immunogens and antibodies and uses thereof
|
|
NZ511705A
(en)
*
|
2001-05-14 |
2004-03-26 |
Horticulture & Food Res Inst |
Methods and rapid immunoassay device for detecting progesterone and other steroids
|
|
EP1406893B1
(en)
*
|
2001-06-15 |
2007-04-18 |
Vicuron Pharmaceuticals, Inc. |
Pyrrolidine bicyclic compounds
|
|
US7115266B2
(en)
*
|
2001-10-05 |
2006-10-03 |
Cytos Biotechnology Ag |
Angiotensin peptide-carrier conjugates and uses thereof
|
|
MXPA04002644A
(es)
|
2001-10-05 |
2004-07-08 |
Cytos Biotechnology Ag |
Conjugados que portan un peptido de angiotensina y usos de los mismos.
|
|
WO2003082329A2
(en)
*
|
2002-03-01 |
2003-10-09 |
The Board Of Regents Of The University Of Nebraska |
Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
|
|
NZ537003A
(en)
|
2002-07-18 |
2008-03-28 |
Cytos Biotechnology Ag |
Hapten-carrier conjugates comprising virus like particles and uses thereof
|
|
DE60329721D1
(de)
*
|
2003-11-17 |
2009-11-26 |
Univ North Carolina State |
Regiospezifische synthese von nikotinderivaten
|
|
US7279340B2
(en)
*
|
2004-04-07 |
2007-10-09 |
Dade Behring Inc. |
Synthesis and application of procainamide analogs for use in an immunoassay
|
|
MXPA04006617A
(es)
|
2004-07-07 |
2006-01-12 |
Inst Nac De Psiquiatria Ramon |
Proceso para la preparacion y uso de una vacuna bivalente contra la adiccion a la morfina-heroina.
|
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
|
FR2877668B1
(fr)
*
|
2004-11-10 |
2007-07-06 |
Gemac Sa |
Procede de couplage de molecules non immunogenes, compose intermediaire, produit final obtenu et utilisations
|
|
US9267937B2
(en)
|
2005-12-15 |
2016-02-23 |
Massachusetts Institute Of Technology |
System for screening particles
|
|
EP2007435B1
(en)
*
|
2006-03-31 |
2019-12-18 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
|
CA2652280C
(en)
|
2006-05-15 |
2014-01-28 |
Massachusetts Institute Of Technology |
Polymers for functional particles
|
|
US20110052697A1
(en)
*
|
2006-05-17 |
2011-03-03 |
Gwangju Institute Of Science & Technology |
Aptamer-Directed Drug Delivery
|
|
US9381477B2
(en)
*
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
|
WO2008019142A2
(en)
*
|
2006-08-04 |
2008-02-14 |
Massachusetts Institute Of Technology |
Oligonucleotide systems for targeted intracellular delivery
|
|
US20100303723A1
(en)
*
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
|
WO2008098165A2
(en)
|
2007-02-09 |
2008-08-14 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
|
JP2010523595A
(ja)
*
|
2007-04-04 |
2010-07-15 |
マサチューセッツ インスティテュート オブ テクノロジー |
ポリ（アミノ酸）ターゲッティング部分
|
|
EP3424525A1
(en)
|
2007-10-12 |
2019-01-09 |
Massachusetts Institute Of Technology |
Vaccine nanotechnology
|
|
EP2300053A1
(en)
*
|
2008-06-04 |
2011-03-30 |
Cornell University |
Vaccines for prevention and treatment of addiction
|
|
US20110182918A1
(en)
|
2008-06-13 |
2011-07-28 |
Nabi Biopharmaceuticals |
Personalized drug treatment and smoking cessation kit and method
|
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
|
US8277812B2
(en)
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
|
CA2754592A1
(en)
|
2009-03-09 |
2010-09-16 |
William Henry |
Hapten-carrier conjugates with bacterial toxins having a signal peptide as carrier and their use in immunogenic compositions
|
|
JP2012524780A
(ja)
*
|
2009-04-21 |
2012-10-18 |
セレクタ バイオサイエンシーズ インコーポレーテッド |
Ｔｈ１バイアス応答をもたらす免疫ナノ治療薬（Ｉｍｍｕｎｏｎａｎｏｔｈｅｒａｐｅｕｔｉｃｓ）
|
|
AR077611A1
(es)
*
|
2009-07-31 |
2011-09-07 |
Nabi Biopharmaceuticals |
Metodo y conjunto de elementos ( kit) para tratar la adiccion a la nicotina. combinacion. uso.
|
|
JP2013504618A
(ja)
*
|
2009-09-14 |
2013-02-07 |
ザ スクリプス リサーチ インスティチュート |
ニコチンハプテン、免疫抱合体およびその使用
|
|
US9682133B2
(en)
|
2010-03-17 |
2017-06-20 |
Cornell University |
Disrupted adenovirus-based vaccine against drugs of abuse
|
|
WO2011123042A1
(en)
*
|
2010-04-01 |
2011-10-06 |
Independent Pharmaceutica Ab |
Vaccination procedure and products for use therein
|
|
GB201006324D0
(en)
|
2010-04-15 |
2010-06-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
WO2011150258A1
(en)
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
TWI455722B
(zh)
*
|
2010-06-04 |
2014-10-11 |
Pfizer Vaccines Llc |
用於預防或治療菸鹼成癮之共軛體
|
|
EA201390660A1
(ru)
|
2010-11-05 |
2013-11-29 |
Селекта Байосайенсиз, Инк. |
Модифицированные никотиновые соединения и связанные способы
|
|
US20130028857A1
(en)
|
2011-07-29 |
2013-01-31 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers comprising polymers comprising multiple immunomodulatory agents
|
|
EP2568289A3
(en)
|
2011-09-12 |
2013-04-03 |
International AIDS Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
|
US10004811B2
(en)
|
2012-04-13 |
2018-06-26 |
Cornell University |
Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addiction
|
|
EP2970319A4
(en)
|
2013-03-14 |
2016-11-09 |
Alere San Diego Inc |
6-ACETYLMORPHINE ANALOGUE AND METHOD FOR THE SYNTHESIS AND USE
|
|
CA2949667C
(en)
|
2014-05-19 |
2022-05-03 |
The Scripps Research Institute |
Enantiopure haptens for nicotine vaccine development
|
|
US20190240306A1
(en)
*
|
2016-10-24 |
2019-08-08 |
The Scripps Research Institute |
Anti-opioid vaccines
|
|
CA3066915A1
(en)
*
|
2017-06-11 |
2018-12-20 |
Molecular Express, Inc. |
Methods and compositions for substance use disorder vaccine formulations and uses thereof
|
|
CN108409749B
(zh)
*
|
2018-01-30 |
2019-09-06 |
中国农业科学院蜜蜂研究所 |
钩吻素己半抗原和全抗原及其制备方法与应用
|
|
US12455283B2
(en)
*
|
2019-01-29 |
2025-10-28 |
Teknologian Tutkimuskeskus Vtt Oy |
Methods for screening polypeptides capable of binding specific target molecules and tools related thereto
|
|
CN113999163A
(zh)
*
|
2021-11-03 |
2022-02-01 |
公安部第三研究所 |
合成大麻素半抗原化合物及其制备方法和用途
|
|
CN115974836A
(zh)
*
|
2023-01-16 |
2023-04-18 |
浙江安诺和生物医药有限公司 |
一种s-(-)-6-甲基尼古丁水杨酸盐及其制备方法
|
|
WO2024238822A1
(en)
*
|
2023-05-17 |
2024-11-21 |
Regents Of The University Of Minnesota |
Heroin vaccine compositions and methods thereof
|
|
CN117865868B
(zh)
*
|
2023-05-19 |
2024-09-06 |
湖南大学 |
一种功能化分子、其制备方法及其应用
|